The antiviral effect was not restricted to the laboratory adapted DENV-2 NGC as G3BP1, G3BP2 and CAPRIN1 had antiviral activity against the clinical DENV-2 isolate PR1940 as well as the related yellow fever vaccine strain (YFV-17D) (Figure S1F). The gene discussed is CAPRIN1; the disease is viral infectious disease.